You hit the nail on the head . Surgical resection is the only small window of hope for these patients . OSL has displayed the devise combined with lower doses of Chemo has the capacity to downsize the tumours to the point where for some surgical resection is possible . Completing randomised trials would not offer any new information , Trials of the Chemo drugs alone have already been completed by their manufacturers It’s up to BSI to evaluate weather they see any advantage in using OSL devise / smaller doses of Chemo compared to Chemo/ standard radiation , OSL is really only proving their radiation devise offers a advantage over standard beam type radiation and it appears BSI has been convinced .
OSL Price at posting:
13.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)